{
    "2019-03-15": [
        [
            {
                "time": "2019-03-15",
                "original_text": "After Hours Most Active for Mar 15, 2019: PFE, VSTM, ZNGA, GE, CSCO, KO, WFC, DO, MSFT, BAC, INTC, HBAN",
                "features": {
                    "keywords": [
                        "PFE",
                        "VSTM",
                        "ZNGA",
                        "GE",
                        "CSCO",
                        "KO",
                        "WFC",
                        "DO",
                        "MSFT",
                        "BAC",
                        "INTC",
                        "HBAN"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "technology",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-15",
                "original_text": "Pharma Stock Roundup: Regulatory Updates From MRK, PFE, J&J, AGN & Others",
                "features": {
                    "keywords": [
                        "MRK",
                        "PFE",
                        "J&J",
                        "AGN",
                        "Regulatory Updates"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-03-15",
                "original_text": "Notable ETF Inflow Detected - SPYG, PFE, BRK.B, PYPL",
                "features": {
                    "keywords": [
                        "SPYG",
                        "PFE",
                        "BRK.B",
                        "PYPL",
                        "ETF Inflow"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance",
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-15",
                "original_text": "Dow 30 Stock Roundup: PFE's Herceptin Biosimilar Gets FDA Nod, VZ to Launch 5G Soon",
                "features": {
                    "keywords": [
                        "PFE",
                        "Herceptin",
                        "FDA",
                        "VZ",
                        "5G"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "telecommunications"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-03-15",
                "original_text": "The Case Against Pfizer Stock and the Rest of the Industry",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Industry"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-03-15",
                "original_text": "Pisani: S&P rebalancing as some companies aggressively buy back stock",
                "features": {
                    "keywords": [
                        "S&P",
                        "rebalancing",
                        "stock buyback"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}